“Whoa! It's like Spotify but for academic articles.”

Instant Access to Thousands of Journals for just $40/month

Get 2 Weeks Free

Integrated cognitive behavioral therapy for cannabis use and anxiety disorders: Rationale and development

1 Introduction</h5> Cannabis use disorders (CUD) are more common than all other illicit substance use disorders (SUD) combined ( Stinson et al., 2006 ). Quitting cannabis is very difficult ( Moore & Budney, 2003 ) and situations involving negative affect (NA) are among the most difficult situations in which to abstain ( Buckner, Zvolensky, & Ecker, 2013 ). Anxiety is one common type of NA that is systematically and uniquely related to CUD (see Buckner, Heimberg, Ecker, & Vinci, 2013 ) and greater anxiety at treatment termination predicts greater post-treatment cannabis use and related problems ( Buckner & Carroll, 2010 ). On the other hand, decreases in anxiety during CUD treatment are related to better outcomes ( Buckner & Carroll, 2010 ). The high rates of co-occurring anxiety and SUD and the poorer outcomes among these patients have led to explicit calls for the development of treatments for dually diagnosed patients ( National Insitute of Drug Abuse, 2013 ), including treating anxiety and SUD in an integrated fashion that addresses the reciprocal nature of these disorders ( Stewart & Conrod, 2008 ).</P>False Safety behavior Elimination Treatment (FSET; Schmidt, Buckner, Pusser, Woolaway-Bickel, & Preston, 2012 ) is a transdiagnostic http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Addictive Behaviors Elsevier
Loading next page...

You're reading a free preview. Subscribe to read the entire article.

And millions more from thousands of peer-reviewed journals, for just $40/month

Get 2 Weeks Free

To be the best researcher, you need access to the best research

  • With DeepDyve, you can stop worrying about how much articles cost, or if it's too much hassle to order — it's all at your fingertips. Your research is important and deserves the top content.
  • Read from thousands of the leading scholarly journals from Springer, Elsevier, Nature, IEEE, Wiley-Blackwell and more.
  • All the latest content is available, no embargo periods.